Inhibitive effect of prodigiosin on the proliferation of human malignant pancreatic cancer cells

Medicinal Chemistry Research

Volumn 14, Issue 4, 2005, Pages 181-197

  Zhang, Jing ^a   Liu, Jianwen ^a   Shen, Yaling ^a   Wei, Dongzhi ^a   Li, Ke ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; PRODIGIOSIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; MITOSIS INHIBITION; PANCREAS CANCER;

EID: 33747140451     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-005-0133-z     Document Type: Article

References (33)

1. Fang Liu. SMAD4/DPC4 and Pancreatic Cancer Survival. Clin. Cancer Res. 2001, 7, 3853-3856.
2. Bomman, P. C.; Beckingham, I. J. ABC of diseases of liver, pancreas, and biliary system: Pancreatic tumours. B. M. J. 2001, 24, 741-743.
3. Mangray, S.; King, T. C. Molecular pathobiology of pancreatic adenocarcinoma. Front. Biosci. 1998, 3, 1148-1160.
4. Maryjean, S.; Ann, G. S.; Erica, O'Neal; Margaret, K.; Joel, K. G.; et al. Familial Risk of Pancreatic Cancer. J. Natl. Cancer I. 2001, 93, 640-644.
5. Pandey, R.; Chander, R.; Sainis, K. B. A novel prodigiosin-like immunosuppressant from an alkalophilic Micrococcussp. Int Immunopharmacol. 2003, 3, 159-167.
6. Tsuji, R.; Magae, J.; Jamashita, M.; Nagai, K.; Yamasaki, M. Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses cytotoxic T cells. J. Antibiot. 1992, 45, 1295-1302.
7. Songia, S.; Mortellaro, A.; Taverna, S.; Fomasiero, C.; Scheiber, E. A.; et al. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J. Immunol. 1997, 158, 3987-3995.
8. Kawauchi, K.; Shibutani, K.; Yagisawa, H.; Kamata, H.; Nakatsuji, S.; et al. A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans. Biochem. Biophys. Res. Commun. 1997, 237, 543-547.
9. Han, S. B.; Kim, H. M.; Kim, Y. H.; Lee, C. W.; Jang E. S.; et al. T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens. Int. J. Immunopharmacol. 1998, 20, 1-13.
10. Lazaro, J.E.; Nitcheu, J.; Predicala, R. Z.; Mangalindan, G. C.; Nesslany, F.; et al. Heptyl prodigiosin, a bacterial metabolite, is antimalarial in vivo and non-mutagenic in vitro. J. Nat. Toxins. 2002, 11, 367-377.
11. Montaner, B.; Navarro, S.; Piqué, M.; Viaseca, M.; Martinell, M.; et al. Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in hematopoietic cancer cell lines. Brit. J. Pharmacol. 2000, 131, 585-593.
12. Melo, P.; Dura'n, N.; Haun, M. Cytotoxicity of prodigiosin and benznidazole on V79 cells. Toxicol. Lett. 2000, 116, 237-242.
13. Montaner, B.; Pe'rez-Toma's, R. Prodigiosin-induced apoptosis in human colon cancer cells. Life Sci. 2001, 68, 2025-2036.
14. Di'az-Rui'z, C.; Montaner, B.; Pe'rez-Toma's, R. Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-. Histol. Histopathol. 2001, 16, 415-421.
15. Montaner, B.; Pe'rez-Toma's, R. Activation of protein kinase C is required for protection of cells against apoptosis induced by the immunosuppressor prodigiosin. Biochem. Pharmcol. 2002, 63, 1-7.
16. Perez-Tomas, R.; Montaner, B. Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells. Histol Histopathol. 2003, 18, 379-385.
17. Davis, W. J.; Ze'ev, R.; Kenneth, D.T. Cellular Thiols and Reactive Oxygen Species in Drug-Induced Apoptosis. J. Pharm. Exper. Therap. 2001, 296, 1-6.
18. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65, 55-56.
19. Bellosillo, B.; Dalmau, M.; Colomer, D.; Gil, J. Involvement of CED-3/ICE proteases in the apoptosis of B- chronic lymphocytic leukemia cells. Blood. 1997, 89, 3378-3384.
20. Jian-Wen Liu; Norio Nagao; Katsuhiro Kageyama; NobuhikoMiwa. Antimetastatic and anti-invasive ability of phospho-ascorbyl palmitate through intracellular ascorbate enrichment and the resultant antioxidant action. Oncol. Res. 1999, 11, 479-487.
21. Neoptolemos, J. P.; Cunningham, D.; Friess, H. Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann. Oncol. 2003, 14, 675-692.
22. Sato, T.; Konno, H.; Tanaka, Y.; Kataoka, T.; Nagai, K.; et al. Prodigiosins as a new group of H+/Cl- symporters that uncouple proton translocators. J. Biol. Chem. 1998, 273, 21455-21462.
23. Ohkuma, S.; Sato, T.; Okamoto, M.; Matsuya, H.; Arai, K.; et al. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport. Bioche. J. 1998, 334, 731-741.
24. Manderville, R. A.; Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products. Curr. Med. Chem. Anti-Canc. Agents 2001, 1, 195-218.
25. Melvin, M. S.; Calcutt, M. W.; Noftle, R. E.; Manderville, R. A. Influence of the a-ring on the redox and nuclease properties of the prodigiosins: importance of the bipyrrole moiety in oxidative DNA cleavage. Chem. Res. Toxicol. 2002, 15, 742-748.
26. Melvin, M.; Tomlinson, J.; Saluta, G.; Kucera, G.; Lindquist, N.; Manderville, R. Double-strand DNA cleavage by cooper-prodigiosin. J. Am. Chem. Soc. 2000, 122, 6333-6334.
27. Melvin, M. S.; Ferguson, D. C.; Lindquist, N.; Manderville, R. A. DNA Binding by 4-Methoxypyrrolic Natural Products. Preference for Intercalation at AT Sites by Tambjamine E and Prodigiosin. J. Org. Chem. 1999, 64, 6861-6869.
28. Perez-Tomas, R.; Montaner, B.; Llagostera, E.; Soto-Cerrato, V. The prodigiosins, proapoptotic drugs with anticancer properties. Biochem. Pharmacol. 2003, 66, 1447-1452.
29. Victor, J. T.; Barry, L. F. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279, 1005-1028.
30. Tsang, W. P.; Chau, S. P.; Kong, S. K.; Fung, K. P.; Kwok, T. T. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci. 2003, 73, 2047-2058.
31. Li, J.; Zuo, L.; Shen, T.; Xu, C. M.; Zhang, Z. N. Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. J. Trace Elem. Med. Biol. 2003, 17, 19-26.
32. Andre, K.; Ningfang, C.; Navdeep, S. C.; Zuohui, S.; Paul, T. S. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 282, 1324-1329.
33. Montaner, B.; Perez-Tomas, R. The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNK. Toxicol Lett. 2002, 24, 93-98.